ASCPprep.com | Clinical Chemistry
Chapter โ Reproductive Endocrinology & Gonadal Function
ASCP Board Exam ยท Lab-Focused Study Guide
Methods ยท Clinical Interpretation ยท Pre-analytical Variables ยท Practice Questions
1 ยท Priority Map & Quick Foundation
| Topic | Priority | Why It's Tested |
|---|---|---|
| HPG axis & gonadotropic vs hypogonadotropic logic | HIGH | The single concept that unlocks every hypogonadism question โ high vs low FSH/LH localizes the lesion. |
| Testosterone: binding, free vs total, diurnal variation | HIGH | SHBG, albumin, "two morning samples," and aging traps are favorite distractors. |
| Klinefelter (47,XXY) vs Turner (45,X) | HIGH | Classic karyotype + hormone pattern recognition; primary (hypergonadotropic) failure. |
| Menstrual cycle hormones & ovulation timing | HIGH | LH surge โ 36 h to ovulation; progesterone proves ovulation; phase-to-hormone matching. |
| PCOS & hyperandrogenism (Rotterdam, DHEAS, 17-OHP) | HIGH | Source-of-androgen logic (ovary vs adrenal vs CAH) is heavily tested. |
| Estrogens E1/E2/E3 โ which dominates when | MEDIUM | Estradiol=repro, Estrone=postmenopausal, Estriol=pregnancy/fetal. |
| Androgen pathway enzymes (5ฮฑ-reductase, aromatase) | MEDIUM | DHT vs T, T:DHT ratio, ambiguous genitalia mechanisms. |
| Amenorrhea work-up & progesterone challenge | MEDIUM | Stepwise algorithm starting with ฮฒ-hCG; outflow vs estrogen problems. |
| Semen analysis markers (fructose, acid phosphatase) | LOW | Source-organ markers and WHO cutoffs appear as single recall items. |
| Testosterone replacement monitoring & contraindications | LOW | "Contraindicated in prostate cancer"; monitor PSA/Hct/lipids. |
๐ฏ Key Point
Focus hard on the FSH/LH localization logic, testosterone binding/timing, the KlinefelterโTurner pair, the LH-surgeโovulationโprogesterone sequence, and PCOS androgen sourcing. Skim deep steroidogenesis enzymology, exact amino-acid detail, and historical background โ the ASCP tests patterns and interpretation, not biochemistry trivia.
Quick Foundation (start here if this is new)
- One control center, two factories. The brain (hypothalamus + pituitary) sends GnRH โ FSH & LH down to the gonads (testis/ovary), which make sex steroids and send feedback back up.
- FSH/LH are the "thermostat reading." If the gonad fails, the brain shouts louder โ FSH/LH go UP (hypergonadotropic = primary gonad problem). If the brain fails, it whispers โ FSH/LH go DOWN (hypogonadotropic = central problem).
- LH drives steroid output; FSH drives gamete production. LHโLeydig cellsโtestosterone; FSHโSertoli cellsโsperm (and inhibin).
- Most testosterone is "locked up." Only ~2โ3% is free and active; the rest rides on SHBG and albumin.
- Estrogen isn't one hormone. Estradiol rules reproductive years, estrone takes over after menopause, estriol dominates pregnancy.
- Progesterone = "pro-gestation." It proves ovulation happened and prepares the secretory endometrium.
- Why it matters clinically: the same low testosterone can mean a failing testis or a failing pituitary โ and the FSH/LH level is what tells the lab which one, directing completely different work-ups.
๐ง Analogy
Think of the HPG axis as a manager (pituitary) e-mailing two factories (gonads). FSH/LH are the e-mails. If a factory stops shipping product (steroids), the manager floods it with e-mails (high FSH/LH = primary failure). If the manager is out sick, the e-mails stop (low FSH/LH = central failure) even though the factories are fine.
| Concept | Plain-English Explanation |
|---|---|
| Hypergonadotropic | Gonad is broken; brain compensates loudly โ high FSH/LH, low sex steroid. |
| Hypogonadotropic | Brain/pituitary is the problem โ low FSH/LH and low sex steroid. |
| Free vs Total testosterone | Total = everything in blood; Free = the small active fraction not bound to protein. |
| SHBG | The "carrier truck" for sex steroids; more SHBG = less free hormone available. |
| Inhibin / AMH | Gonad-made "quiet down" signals and markers that gonadal tissue is present. |
| LH surge | The mid-cycle spike that triggers ovulation ~36 h later. |
2 ยท Core Content โ Analytes & Hormones
Testosterone
| Feature | Details |
|---|---|
| Definition | Principal male androgen; a C19 steroid. |
| Tissue source | Leydig cells (testis); smaller amounts from adrenal & ovary. |
| Control | LH drives synthesis; negative feedback via testosterone + inhibin. |
| Rate-limiting step | Cholesterol โ pregnenolone (stimulated by LH). |
| Binding | ~45% SHBG (tight), ~50% albumin (loose), only 2โ3% free. Bioavailable = free + albumin-bound. |
| Mechanism of change | โ in primary testicular failure (high LH) or central failure (low LH); converted to DHT by 5ฮฑ-reductase in target tissue and to estradiol by aromatase. |
| Clinical significance | Hypogonadism, infertility, PCOS/virilization (females), monitoring replacement. |
| Assay method | Immunoassay for total T; LC-MS/MS = reference method (esp. low levels in women/children). Free T by equilibrium dialysis (gold standard) or calculation from T + SHBG. |
| Key interferences | SHBG shifts (โ with age/estrogen, โ with obesity/insulin) distort total T; immunoassays unreliable at low concentrations. |
Total testosterone can look "normal" while the active free fraction is low โ almost always an SHBG story. Always interpret testosterone with FSH/LH to localize the lesion.
๐งช Pre-analytical โ Testosterone
Serum or plasma; collect in the morning (~0800, peak ~6 AM) because of diurnal variation. Confirm hypogonadism with โฅ2 separate morning samples. Fasting preferred (food lowers T). Avoid acute illness. Hemolysis and SHBG-altering states (pregnancy, thyroid, liver disease) affect results.
FSH & LH (Gonadotropins)
| Feature | Details |
|---|---|
| Source | Anterior pituitary gonadotrophs, driven by pulsatile GnRH. |
| LH action | โ Leydig cells โ testosterone; โ triggers ovulation, supports corpus luteum. |
| FSH action | โ Sertoli cells โ spermatogenesis + inhibin; โ recruits follicles, drives aromatase. |
| Interpretation | High FSH/LH + low steroid = primary (hypergonadotropic) gonadal failure. Low/normal FSH/LH + low steroid = central (hypogonadotropic). |
| FSH>LH clue | In Klinefelter, FSH rises more than LH because damaged tubules under-produce inhibin. |
| Assay | Two-site immunometric (sandwich) immunoassay. |
๐ฏ Key Point
A GnRH stimulation test distinguishes pituitary vs hypothalamic disease: a normal FSH/LH rise points to an intact pituitary โ defect is in the hypothalamus.
Estrogens (E1 Estrone ยท E2 Estradiol ยท E3 Estriol)
| Estrogen | Dominant when | Source / Notes |
|---|---|---|
| Estradiol (E2) | Reproductive years | Most potent; ovarian granulosa cells (aromatase on theca-derived androstenedione). Main repro estrogen. |
| Estrone (E1) | Postmenopause | From peripheral aromatization of adrenal androgens in fat. Weak. |
| Estriol (E3) | Pregnancy | From fetal-placental unit; marker of fetal well-being; unconjugated E3 in the quad screen. |
๐งช Pre-analytical โ Estrogens
Serum; record cycle day (E2 swings across the cycle โ meaningless without timing). LC-MS/MS preferred for low levels (men, children, postmenopausal). Estrogen raises SHBG, indirectly affecting androgen interpretation.
Progesterone
| Feature | Details |
|---|---|
| Source | Corpus luteum (luteal phase); placenta in the 3rd trimester. |
| Action | Converts proliferative โ secretory endometrium; raises basal body temperature; "pro-gestation." |
| Ovulation proof | Mid-luteal progesterone >300 ng/dL (>3 ng/mL) indicates ovulation occurred. |
| Metabolite | Pregnanediol (urinary) = index of endogenous production. |
Supporting Markers โ Inhibin, AMH, SHBG, hCG, 17-OHP, DHEAS
| Marker | What it tells you | High-yield use |
|---|---|---|
| Inhibin B | Sertoli/granulosa product; selectively inhibits FSH | Explains FSH>LH in tubular damage; marker of Sertoli function. |
| AMH | Sertoli (โ)/granulosa (โ); regresses Mรผllerian ducts in males | Marker of testicular tissue in non-palpable testes; ovarian reserve. |
| SHBG | Liver carrier protein | โ age/estrogen/hyperthyroid; โ obesity/insulin/androgen โ shifts free T. |
| hCG | Placental LH-like hormone | First step in amenorrhea = rule out pregnancy; tumor marker; low + in menopause. |
| 17-OH-progesterone | Substrate proximal to 21-hydroxylase block | Elevated in 21-hydroxylase CAH (ambiguous genitalia, 46,XX). |
| DHEAS | Adrenal androgen | Marker of adrenal-origin androgen excess in hyperandrogenic women. |
๐งช Pre-analytical โ Semen analysis
Abstinence 2โ7 days; analyze within 1 h, keep at body temp. Fructose = seminal vesicle function; acid phosphatase / citric acid = prostate function. WHO lower reference: density โฅ15 million/mL.
3 ยท Visual Memory Hooks
๐งฒ "FSH = Factory of Sperm & Hormone-inhibin ยท LH = Leydig & Lutein." FSHโSertoli (sperm + inhibin); LHโLeydig (testosterone) and Luteinizes the ovary.
๐ก๏ธ Estrogen timeline "2-1-3 by life stage": E2 young, E1 old, E3 expecting. Estradiol = reproductive, Estrone = postmenopausal, Estriol = pregnancy.
๐ "High gonadotropins = gonad is the problem." Hypergonadotropic โ the gonad failed; Hypogonadotropic โ the brain failed.
๐ Klinefelter = "XXY, taX too high (FSH), small testes, gyneco." 47,XXY โ high FSH>LH, low T, โestrogen:androgen โ gynecomastia.
โฑ๏ธ "Surge then thirty-six." LH surge โ ovulation ~36 h later โ progesterone rises โ BBT up.
Pattern Triggers โ If you see X โ think Y โ because Z
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| Low testosterone + high FSH/LH | Primary testicular failure (Klinefelter, mumps orchitis) | Gonad can't respond; pituitary compensates loudly. |
| Low testosterone + low/normal FSH/LH | Central (Kallmann, hyperprolactinemia, pituitary) | Inadequate GnRH/gonadotropin drive. |
| Anosmia + hypogonadism | Kallmann syndrome | Defective GnRH neuron migration with olfactory bulb. |
| High T:DHT ratio, 46,XY undervirilized | 5ฮฑ-reductase deficiency | Can't convert TโDHT for external genitalia. |
| 46,XY, female phenotype, testes present | Complete androgen insensitivity | Androgen receptor mutation; AMH still regresses Mรผllerian ducts. |
| Ambiguous genitalia + โ17-OHP, 46,XX | 21-hydroxylase CAH | Cortisol block shunts precursors to androgens. |
| Hirsutism + oligomenorrhea + cysts | PCOS | Hyperandrogenism + chronic anovulation (Rotterdam). |
| โDHEAS | Adrenal androgen source | DHEAS is adrenal-specific. |
| No withdrawal bleed after progesterone | Low estrogen priming or outflow obstruction | Endometrium never primed, or tract blocked (Asherman). |
Commonly Confused Pairs
| Pair | Left | Right |
|---|---|---|
| Klinefelter vs Turner | 47,XXY โ, tall, โFSH, small testes | 45,X โ, short, โFSH, primary amenorrhea |
| 5ฮฑ-reductase def. vs CAIS | Internal โ normal (T ok), external under-virilized; โT:DHT | 46,XY female phenotype; receptor defect; testes, no uterus |
| Estrone vs Estriol | E1 โ postmenopausal, fat-derived | E3 โ pregnancy, fetal-placental |
| Hyper- vs Hypo-gonadotropic | โFSH/LH = gonad failure | โFSH/LH = central failure |
| DHEAS vs 17-OHP | Adrenal androgen excess marker | 21-hydroxylase CAH marker |
Diagnostic Window โ Time-based markers
| Marker / Event | Onset | Peak | Duration | Best Clinical Use |
|---|---|---|---|---|
| LH surge โ ovulation | Surge begins ~36 h pre-ovulation | Ovulation ~36 h after surge onset (~10โ12 h after peak) | Single cycle event | Time intercourse / confirm ovulation |
| Mid-luteal progesterone | Rises after ovulation | Day ~21 (mid-luteal) | ~10โ14 days, falls if no pregnancy | >300 ng/dL confirms ovulation |
| Basal FSH (ovarian reserve) | โ | Day 3 of cycle | Cycle-specific | High day-3 FSH = diminished reserve |
| Testosterone diurnal | Lowest evening | ~6 AM | Daily | Always draw AM; repeat to confirm |
4 ยท Diagnostic Flowcharts
โ Male hypogonadism โ localize the lesion
| Adult male: โ libido, fatigue, small testes โ draw AM testosterone ร2 |
| Low testosterone confirmed โ measure FSH & LH โ |
| FSH/LH HIGH โ primary testicular failure โ karyotype โ 47,XXY Klinefelter (or mumps orchitis, myotonic dystrophy) |
| FSH/LH LOW/normal โ central โ check prolactin, smell, MRI โ Kallmann (anosmia) / hyperprolactinemia / pituitary lesion |
| Diagnosis localized โ primary (gonad) vs secondary (central) hypogonadism |
โ ๏ธ Common mistakeTreating a single low testosterone as diagnostic. Always repeat on a second morning and pair with FSH/LH before labeling hypogonadism.
โก Secondary amenorrhea โ first steps
| No menses โฅ3 months in a woman who previously menstruated โ ฮฒ-hCG first |
| hCG positive โ pregnancy (stop work-up) |
| hCG negative โ prolactin, TSH, FSH โ high FSH (>40 IU/L <40 yr) = primary ovarian insufficiency |
| Normal FSH โ progesterone challenge: withdrawal bleed = anovulation (estrogen present); no bleed = low estrogen or outflow problem |
| No bleed after estrogen+progesterone โ outflow obstruction (Asherman) |
โ ๏ธ Common mistakeOrdering FSH/estrogen before ฮฒ-hCG. Pregnancy is the #1 cause of secondary amenorrhea โ rule it out first, always.
โข Hyperandrogenism in women โ find the source
| Hirsutism + irregular cycles โ measure total/free T, DHEAS, 17-OHP |
| โT, normal DHEAS, โLH:FSH, cysts โ PCOS (Rotterdam: 2 of 3) |
| โโDHEAS โ adrenal source (tumor / adrenal) |
| โ17-OHP โ non-classic 21-hydroxylase CAH |
| Very rapid virilization + very high T/DHEAS โ androgen-secreting tumor |
โ ๏ธ Common mistakeCalling every hirsute woman PCOS. Sudden, severe virilization with sky-high androgens points to a tumor, not PCOS.
โฃ Marker / timing selection in the female cycle
| Question: which test, which day? |
| Assess ovarian reserve โ basal FSH on day 3 (or AMH any day) |
| Confirm ovulation โ progesterone mid-luteal (~day 21), >300 ng/dL |
| Predict ovulation โ urine/serum LH surge (ovulation ~36 h later) |
| Right marker + right day = interpretable result |
โ ๏ธ Common mistakeDrawing progesterone too early. A day-21 (mid-luteal) draw is required; an early-follicular progesterone is always low and proves nothing.
โค Method selection โ measuring low sex steroids
| Need testosterone/estradiol in women, children, or hypogonadal men (low levels) |
| Routine adult male, mid-normal range โ automated immunoassay is acceptable |
| Low concentrations / accuracy critical โ LC-MS/MS (reference method) |
| Need true free testosterone โ equilibrium dialysis (gold standard) or calculate from T + SHBG |
| Match assay sensitivity to the expected concentration |
โ ๏ธ Common mistakeTrusting an immunoassay free-T or a low-level immunoassay result. At low concentrations immunoassays are inaccurate โ switch to LC-MS/MS or dialysis.
5 ยท 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | High FSH/LH with low sex steroid = primary (hypergonadotropic) gonadal failure. |
| 2 | Low/normal FSH/LH with low sex steroid = central (hypogonadotropic) failure. |
| 3 | LH acts on Leydig cells to make testosterone; FSH acts on Sertoli cells for spermatogenesis. |
| 4 | Rate-limiting step of steroidogenesis is cholesterol โ pregnenolone. |
| 5 | Only 2โ3% of testosterone is free; ~45% on SHBG, ~50% on albumin. |
| 6 | Bioavailable testosterone = free + albumin-bound fractions. |
| 7 | Testosterone peaks ~6 AM โ always draw morning samples, confirm on two mornings. |
| 8 | SHBG rises with age and estrogen, so total T can look normal while free T is low. |
| 9 | 5ฮฑ-reductase converts testosterone โ DHT, required for male external genitalia. |
| 10 | Aromatase converts androgens โ estrogens (granulosa cells; peripheral fat). |
| 11 | Klinefelter is 47,XXY: high FSH>LH, low T, gynecomastia, small firm testes. |
| 12 | FSH>LH in Klinefelter because damaged tubules under-produce inhibin. |
| 13 | Kallmann syndrome = hypogonadotropic hypogonadism + anosmia. |
| 14 | Hyperprolactinemia causes hypogonadism by suppressing pulsatile GnRH. |
| 15 | Complete androgen insensitivity: 46,XY, female phenotype, testes, no uterus (AMH acted). |
| 16 | High testosterone-to-DHT ratio indicates 5ฮฑ-reductase deficiency. |
| 17 | Turner syndrome is 45,X: short stature, primary amenorrhea, high FSH. |
| 18 | Estradiol = reproductive years; estrone = postmenopausal; estriol = pregnancy. |
| 19 | Unconjugated estriol (uE3) is the estrogen in the Down-syndrome quad screen. |
| 20 | Progesterone from the corpus luteum drives the secretory endometrium and raises BBT. |
| 21 | Mid-luteal progesterone >300 ng/dL confirms ovulation occurred. |
| 22 | Ovulation occurs ~36 hours after the LH surge begins. |
| 23 | PCOS (Rotterdam) needs 2 of 3: hyperandrogenism, oligo/anovulation, polycystic ovaries. |
| 24 | โ17-OHP with ambiguous genitalia (46,XX) = 21-hydroxylase CAH; โDHEAS = adrenal source. |
| 25 | Secondary amenorrhea work-up starts by ruling out pregnancy with ฮฒ-hCG. |
โญ Exam Tip โ single most testable pattern
Whenever you see low sex steroid, your reflex must be: look at FSH/LH. High = the gonad failed (primary). Low = the brain failed (central). This one fork answers more questions on this chapter than any other fact.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| โ Testosterone + โ FSH/LH | Primary testicular failure (e.g., Klinefelter, orchitis). |
| โ Testosterone + โ FSH/LH | Central/secondary hypogonadism (Kallmann, prolactinoma). |
| โ FSH on day 3 / โ FSH >40 IU/L | Diminished ovarian reserve / primary ovarian insufficiency. |
| Mid-luteal progesterone >300 ng/dL | Ovulation has occurred. |
| โ DHEAS | Adrenal-origin androgen excess. |
| โ 17-OH-progesterone | 21-hydroxylase deficiency (CAH). |
| โ T:DHT ratio | 5ฮฑ-reductase deficiency. |
| Positive ฮฒ-hCG in amenorrhea | Pregnancy โ the first thing to exclude. |
8 ยท ๐ Rapid Revision โ READ 2 HOURS BEFORE YOUR EXAM
Testosterone numbers
- Free T: 2โ3%
- SHBG-bound ~45% ยท albumin ~50%
- Peak ~6 AM ยท confirm ร2 mornings
- โ ~110 ng/dL per decade after 30
FSH/LH localization
- โFSH/LH = primary (gonad)
- โFSH/LH = central (brain)
- FSH>LH โ โinhibin (tubular damage)
Ovulation timing
- LH surge โ ovulation ~36 h
- Progesterone >300 ng/dL = ovulated
- Basal FSH: day 3 ยท Progesterone: ~day 21
- Blood loss/menses: 30โ50 mL
Estrogens (opposites)
- E2 estradiol = reproductive
- E1 estrone = postmenopausal
- E3 estriol = pregnancy/fetal
- uE3 = quad screen
Karyotypes
- Klinefelter 47,XXY (tall โ, โFSH)
- Turner 45,X (short โ, โFSH)
- CAIS 46,XY female phenotype
- CAH 46,XX ambiguous, โ17-OHP
Androgen source
- โDHEAS = adrenal
- โ17-OHP = 21-OHase CAH
- โT:DHT = 5ฮฑ-reductase def.
- PCOS = โLH:FSH, cysts
Cutoffs / criteria
- PCOS Rotterdam: 2 of 3
- FSH >40 IU/L = ovarian failure (<40 yr)
- Sperm density โฅ15 million/mL
- Infertility = 1 yr unprotected
Confusing pairs
- Hyper- vs Hypo-gonadotropic
- 5ฮฑ-reductase def. vs CAIS
- DHEAS vs 17-OHP
- E1 vs E3
Seminal markers
- Fructose = seminal vesicles
- Acid phosphatase = prostate
- Azoospermia = no sperm
- TRT contraindicated: prostate CA
9 ยท ๐บ๏ธ Final Memory Map
REPRODUCTIVE ENDOCRINOLOGY
HPG Axis (control logic)
GnRH (pulsatile) โ FSH & LH โ gonad โ steroids + inhibin feedback
โFSH/LH = primary gonad failure ยท โFSH/LH = central failure
GnRH stim test: normal rise โ defect is hypothalamic
Male axis
LHโLeydigโtestosterone ยท FSHโSertoliโsperm + inhibin/AMH
T binding: 2โ3% free, SHBG + albumin; peak 6 AM, confirm ร2
TโDHT (5ฮฑ-reductase, external genitalia) ยท TโE2 (aromatase)
Disorders: Klinefelter 47,XXY ยท Kallmann (anosmia) ยท CAIS 46,XY ยท 5ฮฑ-reductase def (โT:DHT)
Female axis
Follicular (estradiol, proliferative) โ LH surge โ ovulation 36 h โ luteal (progesterone, secretory)
Thecaโandrostenedione โ granulosa aromataseโestradiol
Progesterone >300 ng/dL = ovulated ยท BBT rises ยท pregnanediol metabolite
Estrogens: E2 repro ยท E1 postmenopausal ยท E3 pregnancy (uE3 quad screen)
Female disorders
Turner 45,X ยท PCOS (Rotterdam 2/3, โLH:FSH) ยท CAH 46,XX โ17-OHP ยท Asherman (outflow)
Amenorrhea work-up: ฮฒ-hCG first โ prolactin/TSH/FSH โ progesterone challenge
Androgen source: โDHEAS adrenal ยท โ17-OHP CAH
Lab methods & pre-analytical
LC-MS/MS for low levels ยท equilibrium dialysis = free T gold standard
Semen: fructose (seminal vesicle) ยท acid phosphatase (prostate) ยท โฅ15 million/mL
TRT: contraindicated in prostate CA; monitor PSA/Hct/lipids q3โ6 mo